Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × ribociclib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 52 Neoplasm Metastasis 5 Neoplasms 4 Endometrial Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Ovarian Neoplasms 3 Melanoma 3 Glioma 3 Colorectal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neuroblastoma 2 Neoplasms by Site 2 Lung Neoplasms 2 Glioblastoma 2 Breast Diseases 2 Brain Neoplasms 2 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Rhabdomyosarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Medulloblastoma 1 Locoregional Recurrence 1

Interventions

Cyclophosphamide 5 Radiotherapy 3 Automobiles 3 fludarabine 2 Vincristine 2 Temozolomide 2 Eflornithine 2 Cisplatin 2 omburtamab I-131 1 ibrutinib 1 gallium Ga 68 dotatate 1 belzutifan 1 Zoledronic Acid 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Pemetrexed 1 ONC206 1 Nivolumab 1 Maintenance Chemotherapy 1 Lomustine 1 Infusions, Intravenous 1 Induction Chemotherapy 1 HhAntag691 1 Gemcitabine 1 Exercise 1 Etoposide 1 Drug Therapy 1 Diploidy 1 Craniospinal Irradiation 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡